Top compounds associated with response to ATG13


Feature Type Standardized
Nominal ANOVA
mRNA PL-DI CTRPv2 pan-cancer AAC 0.064 0.04
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.071 0.04
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.04
mRNA UNC0638 GDSC1000 pan-cancer AAC 0.059 0.04
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.11 0.04
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC 0.15 0.04
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.05
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.073 0.05
mRNA CGP-60474 GDSC1000 pan-cancer AAC -0.1 0.05
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.065 0.05
Download CSV